Publication | Open Access
VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer
583
Citations
15
References
2017
Year
Ipilimumab TherapyMedicineImmunologyImmune Checkpoint InhibitorCancer TreatmentProstatic DiseaseImmunotherapyOncologyRadiation OncologyInhibitory Immune Checkpoint
| Year | Citations | |
|---|---|---|
Page 1
Page 1